Skip to main content

Advertisement

ADVERTISEMENT

Q&As

Alexis Ogdie, MD
Q&As
10/04/2023
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions...
10/04/2023
Rheumatology & Arthritis
Dr Ching-Lung Cheung
Q&A
09/29/2023
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few...
09/29/2023
Rheumatology & Arthritis
Monica Schwartzman
Q&A
08/21/2023
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our...
08/21/2023
Rheumatology & Arthritis

Advertisement

Lars Klareskog, MD
Q&A
08/08/2023
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a...
08/08/2023
Rheumatology & Arthritis
Yassein Shamout, MD, FRCPC, DABD
Q&As
06/20/2023
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in...
06/20/2023
The Dermatologist
Jennifer L Barton, MD, MCR
Q&As
01/06/2023
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton...
01/06/2023
Rheumatology & Arthritis

Advertisement

Saundra Jain
Q&A
09/30/2022
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS,...
09/30/2022
Rheumatology & Arthritis
Dana Villmore
Q&A
07/20/2022
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD,...
07/20/2022
Rheumatology & Arthritis
Betty Hsaio
Q&A
07/19/2022
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale...
07/19/2022
Rheumatology & Arthritis

Advertisement

Alexis Ogdie
Q&A
06/29/2022
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving...
06/29/2022
Rheumatology & Arthritis

Advertisement